Convergent evidence and opinion on intensive metabolic support

摘要

The translation of clinical research findings in nutrition and metabolism to clinical practice of intensive metabolic support (IMS) in the ICU has followed an alternating pattern of brief spurts following landmark studies and organized corrections as information is vetted. This past year is no exception as the story of intensive insulin therapy (IIT) and companion role of parenteral nutrition in the ICU was scientifically studied in a highly controlled experimental design. Indeed, 2011 will remain as one of the most productive years in ICU nutrition and metabolism. In response to this event, we invited experts to provide their opinions regarding different aspects of IMS, from nutritional assessment to glycemic control to enteral nutrition to parenteral nutrition and finally, to nutritional pharmacology, all in an effort to garner perspective when interpreting new data.